Addiction is a sickness that affects everyone equally. It affects people from every ethnicity, religion, class, and vocation throughout the whole planet. However, despite the fact that addiction is so pervasive and may afflict anybody, there are still certain persistent myths and stigmas associated with it. Therefore, knowledge about addiction is crucial and helpful, especially for those who are experiencing addiction firsthand or who have been impacted by it due to a loved one's addiction. People who are educated about addiction are better able to comprehend the experience of addiction, how to support a beloved one, how to seek assistance, and which therapies may be most successful. Nobody contests the extent of the country's drug crisis or its catastrophic effects on millions of lives. Alcohol and narcotics, especially among the nation's youth, damage health and ruin prospects. Experts are developing educational programmes that employ concrete proof training to help community people become aware of peer influence, mental health issues, prescription drug usage, preventative strategies, and much more in order to address growing trends in alcoholism and addiction overdoses.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States